Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy

American Heart Journal

Volumn 159, Issue 5, 2010, Pages 809-816

  Herda, Lars R ^a   Trimpert, Christiane ^a   Nauke, Ute ^a   Landsberger, Martin ^a   Hummel, Astrid ^a   Beug, Daniel ^a   Kieback, Arne ^a   Dörr, Marcus ^a   Empen, Klaus ^a   Knebel, Fabian ^b   Ewert, Ralf ^a   Angelow, Aniela ^a   Hoffmann, Wolfgang ^a   Felix, Stephan B ^a   Staudt, Alexander ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; SPIRONOLACTONE; UNCLASSIFIED DRUG; VENIMMUN N;

ADULT; ARTICLE; CARDIOPULMONARY FUNCTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOADSORPTION; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THERAPY EFFECT;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; ERGOMETRY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY, WHOLE BODY; STROKE VOLUME; SURFACE PLASMON RESONANCE;

EID: 77951541199     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.01.012     Document Type: Article

References (34)

1. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
2. Baba A., Yoshikawa T., and Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1153-1159
3. Caforio A.L., Grazzini M., Mann J.M., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85 (1992) 1734-1742
4. Wallukat G., Wollenberger A., Morwinski R., et al. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27 (1995) 397-406
5. Jahns R., Boivin V., Hein L., et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113 (2004) 1419-1429
6. Cohen-Solal A., Zannad F., Kayanakis J.G., et al. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group. Eur Heart J 12 (1991) 1055-1063
7. Bard R.L., Gillespie B.W., Clarke N.S., et al. Combining peak oxygen consumption and ventilatory efficiency in the prognostic assessment of patients with heart failure. Int J Cardiol 123 (2008) 199-200
8. Arena R., Myers J., Abella J., et al. Development of a ventilatory classification system in patients with heart failure. Circulation 115 (2007) 2410-2417
9. Dorffel W.V., Felix S.B., Wallukat G., et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95 (1997) 1994-1997
10. Felix S.B., Staudt A., Dorffel W.V., et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35 (2000) 1590-1598
11. Staudt A., Schaper F., Stangl V., et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103 (2001) 2681-2686
12. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 (2008) 2388-2442
13. Staudt A., Hummel A., Ruppert J., et al. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 152 (2006) 712.e1-712.e6
14. Cheitlin M.D., Alpert J.S., Armstrong W.F., et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 95 (1997) 1686-1744
15. Jones N. Clinical exercise testing. 3rd ed (1988), W. B. Saunders, Philadelphia
16. Beaver W.L., Wasserman K., and Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60 (1986) 2020-2027
17. Bard R.L., Gillespie B.W., Clarke N.S., et al. Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure. J Heart Lung Transplant 25 (2006) 589-595
18. Landsberger M., Staudt A., Choudhury S., et al. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Am Heart J 156 (2008) 92-99e2
19. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 29 (1997) 1585-1590
20. Martino T.A., Liu P., and Sole M.J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74 (1994) 182-188
21. Muller J., Wallukat G., Dandel M., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101 (2000) 385-391
22. Kleber F.X., Vietzke G., Wernecke K.D., et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 101 (2000) 2803-2809
23. Corra U., Mezzani A., Bosimini E., et al. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 143 (2002) 418-426
24. Bruggemann M., Williams G.T., Bindon C.I., et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166 (1987) 1351-1361
25. Kindermann I., Kindermann M., Kandolf R., et al. Predictors of outcome in patients with suspected myocarditis. Circulation 118 (2008) 639-648
26. Doesch A.O., Konstandin M., Celik S., et al. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. J Clin Apher 24 (2009) 141-149
27. Roifman C.M., Levison H., and Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1 (1987) 1075-1077
28. Yu Z., and Lennon V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 340 (1999) 227-228
29. Gullestad L., Aass H., Fjeld J.G., et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103 (2001) 220-225
30. McNamara D.M., Holubkov R., Starling R.C., et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
31. Staudt A., Bohm M., Knebel F., et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106 (2002) 2448-2453
32. Hamroff G., Katz S.D., Mancini D., et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 99 (1999) 990-992
33. Dubach P., Myers J., Bonetti P., et al. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. Am Heart J 143 (2002) 676-683
34. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853